Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression
Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr, Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr
Abstract
Background: Ketamine rapidly improves depressive symptoms in patients with treatment-resistant major depressive disorder (MDD) who do not respond to multiple standard antidepressants. However, it remains unknown whether ketamine is equally effective in patients with MDD who previously also did not respond to electroconvulsive therapy (ECT).
Methods: This study compared 17 patients with treatment-resistant MDD who previously did not respond to ECT and 23 patients with treatment-resistant MDD who had not previously received ECT. All subjects received a single open-label infusion of ketamine (0.5 mg/kg). Patients were evaluated using the Montgomery-Asberg Depression Rating Scale (MADRS) at baseline (60 min before the infusion), as well as at 40, 80, 120, and 230 min after infusion.
Results: Depressive symptoms were significantly improved in the ECT-resistant group at 230 minutes with a moderate effect size (p < .001, d = 0.50, 95% C.I.: 0.21-0.80). At 230 minutes, the non-ECT exposed group showed significant improvement with a large effect size (p < .001, d=1.00, 95% C.I.: 0.71-1.29).
Conclusion: Ketamine appears to improve depressive symptoms in patients with MDD who had previously not responded to ECT. These preliminary results encourage further investigation with a larger sample size to determine effectiveness compared to other treatment-resistant patients with MDD.
Published by Elsevier Inc.
Figures


Source: PubMed
Tulevat kliiniset tutkimukset
-
Shirley Ryan AbilityLabKiwanis Neurological Research FoundationRekrytointiTBI:n traumaattinen aivovaurioYhdysvallat
-
University of ChicagoNational Heart, Lung, and Blood Institute (NHLBI)Ei vielä rekrytointiaLaskimotromboembolia | Lantion kirurgia | VatsasyöpäkirurgiaYhdysvallat
-
Fundacion para la Investigacion Biomedica del Hospital...Hospital Universitario La FeRekrytointi
-
Lumetry Diagnostics GmbHKarl Landsteiner Institute for Lung Research and Pneumological Oncology; Klinik FloridsdorfEi vielä rekrytointiaKeuhkosairaus, krooninen obstruktiivinen | HyperkapniaItävalta
-
Beijing Suncadia Pharmaceuticals Co., LtdRekrytointi
-
IpsenEi vielä rekrytointia
-
Xiangya Hospital of Central South UniversityEi vielä rekrytointiaPlakkipsoriaasi | DyslipidemiaKiina
-
Halic UniversityEi vielä rekrytointiaUnen laatu | Ruokavalion interventio | Koettu stressi | AivosumuTurkki (Türkiye)
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityEi vielä rekrytointiaMetastaattinen rintasyöpä | Hormonireseptoripositiivinen rintasyöpä | HER2-matala rintasyöpäKiina
-
The 108 Military Central HospitalVietnam Military Medical University; Thanh Phuong Co., LtdEi vielä rekrytointiaSeptinen shokki | Akuutti munuaisvaurioVietnam
-
University Hospital, MontpellierEi vielä rekrytointiaHemipareesi | Spastisuus | Yläraajojen spastisuusRanska
-
Kasr El Aini HospitalRekrytointiIdiopaattinen granulomatoottinen utaretulehdusEgypti